Arrowhead Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for…

Biotechnology
US, Pasadena [HQ]
Lobbying · US Senate · Influence

Lobbying Analysis

Arrowhead Pharmaceuticals, Inc. has no lobbying expenses in our database.
FY Quarter Lobby Expense [in mil. $] Filing Report Time
No data
End of ARWR's Analysis
CIK: 879407 CUSIP: 04280A100 ISIN: US04280A1007 LEI: - UEI: -
Secondary Listings
ARWR has no secondary listings inside our databases.